Business Wire04.04.19
Fist Assist Devices LLC, a medical device startup based in Silicon Valley, Calif., has formed its first global medical advisory board (MAB).
Fist Assist Devices LLC has developed the only wearable patent-protected intermittent compression device for vein dilation for patients with end-stage renal disease (ESRD). The non-invasive device provides intermittent pressure to a specific arm vein, with the goal of helping dilate the vein after fistula placement. Providing better vein dilation for hemodialysis patients can ensure that the fistula reaches optimal size without delays or extra procedures, ultimately reducing costs for both patients and the dialysis providers.
“As Fist Assist Devices prepares for its global commercialization launch, initially commencing in India this summer, the global MAB was developed to counsel the company on maximizing opportunities to advance outcomes, lower costs and improve patients’ end-stage renal disease journey,” said Tej Singh M.D., CEO and founder of Fist Assist Devices.
The new global MAB advisors include:
“I am thrilled to be associated with Fist Assist Devices LLC and its revolutionary device to assist in vein dilation. The device will be critical for patients with stage 4 or 5 kidney failure as they manage through end-stage renal disease,” said Ross, a globally renowned vascular access thought leader and chair of the newly formed MAB. “Fist Assist is the missing link to managing ESRD patients because the device has the potential to significantly lower costs for patients and the healthcare system, from fistula placement to maturation.”
Fist Assist Devices LLC is a privately held company that has developed the patent-protected Fist Assist technology over the past 30 years. Fist Assist Devices develops and markets an intermittent, external wearable pneumatic compression to increase arm vein enhancement and AV fistula dilation. The device is currently approved for sales in India but is not yet commercially available in Europe or the United States.
Fist Assist Devices LLC has developed the only wearable patent-protected intermittent compression device for vein dilation for patients with end-stage renal disease (ESRD). The non-invasive device provides intermittent pressure to a specific arm vein, with the goal of helping dilate the vein after fistula placement. Providing better vein dilation for hemodialysis patients can ensure that the fistula reaches optimal size without delays or extra procedures, ultimately reducing costs for both patients and the dialysis providers.
“As Fist Assist Devices prepares for its global commercialization launch, initially commencing in India this summer, the global MAB was developed to counsel the company on maximizing opportunities to advance outcomes, lower costs and improve patients’ end-stage renal disease journey,” said Tej Singh M.D., CEO and founder of Fist Assist Devices.
The new global MAB advisors include:
- Dr. John Ross (Orangeburg, S.C.), medical director, Dialysis Access Institute, Regional Medical Center
- Dr. Alexandros Mallios (Paris, France), Vascular Surgery faculty, Institut Mutualiste Montsouris
- Dr. Sanjay Desai (Bangalore, India), chief, Vascular Surgery, MS Ramaiah Memorial Hospital
- Dr. Jaime Velez (Cali, Colombia), chief, Vascular Surgery, Clinica Farallones
- Dr. Jackie Ho Pei (Singapore), director, Endovascular Therapy, Vascular Surgery Division, National University Heart Centre
“I am thrilled to be associated with Fist Assist Devices LLC and its revolutionary device to assist in vein dilation. The device will be critical for patients with stage 4 or 5 kidney failure as they manage through end-stage renal disease,” said Ross, a globally renowned vascular access thought leader and chair of the newly formed MAB. “Fist Assist is the missing link to managing ESRD patients because the device has the potential to significantly lower costs for patients and the healthcare system, from fistula placement to maturation.”
Fist Assist Devices LLC is a privately held company that has developed the patent-protected Fist Assist technology over the past 30 years. Fist Assist Devices develops and markets an intermittent, external wearable pneumatic compression to increase arm vein enhancement and AV fistula dilation. The device is currently approved for sales in India but is not yet commercially available in Europe or the United States.
